Clinical Trial Update: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian [Phase 1]

View source ↗

Summary

Phase I study evaluating autologous CAR T-cells targeting B7-H3 in recurrent epithelial ovarian cancer has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Autologous CAR T cells targeting B7-H3 (B7-H3-targeted autologous CAR T cells)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Epithelial Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-22